Market Cap 157.00M
Revenue (ttm) 90.05M
Net Income (ttm) -38.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -42.28%
Debt to Equity Ratio -9.19
Volume 125,000
Avg Vol 212,096
Day's Range N/A - N/A
Shares Out 47.29M
Stochastic %K 9%
Beta 1.59
Analysts Strong Sell
Price Target $7.75

Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolve...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 866 259 5644
Address:
CAP Business Center, Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts, Herstal, Belgium
nathan_moore19
nathan_moore19 Dec. 11 at 7:49 PM
$MDXH Mainz Biomed is basically on sale under everyone’s average, and yet no waterfall selling shows up, I see that as conviction holding and a spring coiling at the bottom 💎
0 · Reply
UngenauOrange
UngenauOrange Nov. 22 at 8:24 PM
$MDXH Some naive thoughts on Q4 revenue. So while they did not improve full year guidance I feel like there is a strong chance to beat the existing one. They only had 1/6th quarter contribution from Exo in Q3. So since Exo is 25mm a year minus 5mm that should add $4M on top of Q3. Resolve had such an unbelievable QoQ growth. I wonder if there was some one time effect or if this could possibly continue. If so that could be another say 2-3mm. The tissue ASP seems to fluctuate a bit and Q3 was on the low side. If that returns to the mean that could be an additional 1mm. And possibly some of their exo/tissue cross opportunity materializes. Combined I get to around $31.5 - $35.5+ for Q4. So my low side would be on the high side of the full year guidance. And on the high side that would be an anualized $140M without germline and organic growth. Any thoughts? Or is this just idle speculation?
1 · Reply
_www_larval_com_
_www_larval_com_ Nov. 18 at 2:42 PM
$VRA -10%[8%] $MDXH 8%[-4%] $VNDA 5%[13%] $VTYX 4%[3%] $NNOX 3%[13%] most notable movement within the first minutes of trading.
0 · Reply
slick3333
slick3333 Nov. 18 at 2:36 PM
$MDXH anyone know what the offering amount was for??
1 · Reply
slick3333
slick3333 Nov. 17 at 11:17 PM
$MDXH they are diluting now and will make announcement probably within the next few days….and do an offering at the low doscounted price …..
1 · Reply
Goodstockday
Goodstockday Nov. 17 at 4:24 PM
$MDXH I really do not understand the price volatility in this stock. They show a steady pattern of market growth, but it has big swings in stock price. I have used that volatility to buy low and sell high, yet I still do not understand the driving forces at work here. It has hit that point again where I start making buys.
2 · Reply
Kastila
Kastila Nov. 16 at 6:01 PM
$MDXH Its 1.50 cents now. Thank you for shorting.
1 · Reply
slick3333
slick3333 Nov. 14 at 3:17 PM
$MDXH dang it’s over
2 · Reply
slick3333
slick3333 Nov. 13 at 11:01 PM
$MDXH dang broke under 4 whack…all the upgrades won’t mattter as soon as people here hold or shift strategy on something that brings revenue
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:55 PM
TD Cowen has adjusted their stance on MDxHealth ( $MDXH ), setting the rating to Buy with a target price of 5 → 7.
0 · Reply
Latest News on MDXH
MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 11:11 PM EST - 4 weeks ago

MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript


Angle PLC Announces Strategy Update

Oct 8, 2025, 2:00 AM EDT - 2 months ago

Angle PLC Announces Strategy Update


MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript

May 14, 2025, 9:57 PM EDT - 7 months ago

MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript


MDxHealth Reports Q1-2025 Results

May 14, 2025, 4:00 PM EDT - 7 months ago

MDxHealth Reports Q1-2025 Results


MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 8:57 PM EST - 10 months ago

MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript


MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics

Dec 13, 2024, 10:15 AM EST - 1 year ago

MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics


MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:13 AM EST - 1 year ago

MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript


MDxHealth Announces Pricing of Offering of Ordinary Shares

Sep 25, 2024, 9:31 PM EDT - 1 year ago

MDxHealth Announces Pricing of Offering of Ordinary Shares


MDxHealth Announces Launch of Offering of Ordinary Shares

Sep 25, 2024, 4:05 PM EDT - 1 year ago

MDxHealth Announces Launch of Offering of Ordinary Shares


MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 4:34 AM EDT - 1 year ago

MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript


MDxHealth Reports Q2 and Half Year 2024 Results

Aug 21, 2024, 4:00 PM EDT - 1 year ago

MDxHealth Reports Q2 and Half Year 2024 Results


Mdxhealth Appoints Sanford J. Siegel, M.D.

Jul 8, 2024, 8:00 AM EDT - 1 year ago

Mdxhealth Appoints Sanford J. Siegel, M.D.


Mdxhealth to Present at Upcoming Investor Conferences

May 15, 2024, 4:00 PM EDT - 1 year ago

Mdxhealth to Present at Upcoming Investor Conferences


MDxHealth SA (MDXH) Q1 2024 Earnings Call Transcript

May 4, 2024, 11:49 AM EDT - 1 year ago

MDxHealth SA (MDXH) Q1 2024 Earnings Call Transcript


MDxHealth SA (MDXH) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 9:07 PM EST - 1 year ago

MDxHealth SA (MDXH) Q4 2023 Earnings Call Transcript


Mdxhealth Announces Resignation of Board Member

Feb 16, 2024, 8:45 AM EST - 1 year ago

Mdxhealth Announces Resignation of Board Member


MDxHealth SA (MXDHF) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 5:33 PM EST - 2 years ago

MDxHealth SA (MXDHF) Q3 2023 Earnings Call Transcript


Mdxhealth's New Share Capital Amount and New Number of Shares

Oct 20, 2023, 4:00 PM EDT - 2 years ago

Mdxhealth's New Share Capital Amount and New Number of Shares


MDxHealth Reports Preliminary Q3-2023 Revenues

Oct 9, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Preliminary Q3-2023 Revenues


MDxHealth SA (MXDHF) Q2 2023 Earnings Call Transcript

Aug 23, 2023, 8:41 PM EDT - 2 years ago

MDxHealth SA (MXDHF) Q2 2023 Earnings Call Transcript


MDxHealth Reports Q2 and Half Year 2023 Results

Aug 23, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Q2 and Half Year 2023 Results


MDxHealth SA (MXDHF) Q1 2023 Earnings Call Transcript

May 15, 2023, 9:24 PM EDT - 2 years ago

MDxHealth SA (MXDHF) Q1 2023 Earnings Call Transcript


MDxHealth Reports Q1-2023 Results

May 15, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Q1-2023 Results


nathan_moore19
nathan_moore19 Dec. 11 at 7:49 PM
$MDXH Mainz Biomed is basically on sale under everyone’s average, and yet no waterfall selling shows up, I see that as conviction holding and a spring coiling at the bottom 💎
0 · Reply
UngenauOrange
UngenauOrange Nov. 22 at 8:24 PM
$MDXH Some naive thoughts on Q4 revenue. So while they did not improve full year guidance I feel like there is a strong chance to beat the existing one. They only had 1/6th quarter contribution from Exo in Q3. So since Exo is 25mm a year minus 5mm that should add $4M on top of Q3. Resolve had such an unbelievable QoQ growth. I wonder if there was some one time effect or if this could possibly continue. If so that could be another say 2-3mm. The tissue ASP seems to fluctuate a bit and Q3 was on the low side. If that returns to the mean that could be an additional 1mm. And possibly some of their exo/tissue cross opportunity materializes. Combined I get to around $31.5 - $35.5+ for Q4. So my low side would be on the high side of the full year guidance. And on the high side that would be an anualized $140M without germline and organic growth. Any thoughts? Or is this just idle speculation?
1 · Reply
_www_larval_com_
_www_larval_com_ Nov. 18 at 2:42 PM
$VRA -10%[8%] $MDXH 8%[-4%] $VNDA 5%[13%] $VTYX 4%[3%] $NNOX 3%[13%] most notable movement within the first minutes of trading.
0 · Reply
slick3333
slick3333 Nov. 18 at 2:36 PM
$MDXH anyone know what the offering amount was for??
1 · Reply
slick3333
slick3333 Nov. 17 at 11:17 PM
$MDXH they are diluting now and will make announcement probably within the next few days….and do an offering at the low doscounted price …..
1 · Reply
Goodstockday
Goodstockday Nov. 17 at 4:24 PM
$MDXH I really do not understand the price volatility in this stock. They show a steady pattern of market growth, but it has big swings in stock price. I have used that volatility to buy low and sell high, yet I still do not understand the driving forces at work here. It has hit that point again where I start making buys.
2 · Reply
Kastila
Kastila Nov. 16 at 6:01 PM
$MDXH Its 1.50 cents now. Thank you for shorting.
1 · Reply
slick3333
slick3333 Nov. 14 at 3:17 PM
$MDXH dang it’s over
2 · Reply
slick3333
slick3333 Nov. 13 at 11:01 PM
$MDXH dang broke under 4 whack…all the upgrades won’t mattter as soon as people here hold or shift strategy on something that brings revenue
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:55 PM
TD Cowen has adjusted their stance on MDxHealth ( $MDXH ), setting the rating to Buy with a target price of 5 → 7.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:13 PM
Lake Street has adjusted their stance on MDxHealth ( $MDXH ), setting the rating to Buy with a target price of 7 → 9.
0 · Reply
Investor6
Investor6 Nov. 13 at 10:17 AM
2025 acquisitions for small-medium caps: $BNZI estimates $27M revenues by Act-One Software acquisition #NISN estimates to double its revenues by Zhetai acquisition $MDXH acquired Exosome Diagnostics $SERV announced the acquisition of Vayu and Phantom Auto.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 10:12 AM
BTIG has updated their rating for MDxHealth ( $MDXH ) to Buy with a price target of 7.
0 · Reply
Goodstockday
Goodstockday Nov. 12 at 9:46 PM
$MDXH Setting new industry standard for turn around time. In 3Q, used less than 1 million of cash. (So close to break even in terms of cash.) May be partner opportunities to expand to other kinds of cancer.
0 · Reply
Goodstockday
Goodstockday Nov. 12 at 9:30 PM
$MDXH Downward move today just prior to earnings does not much sense.
0 · Reply
slick3333
slick3333 Nov. 12 at 4:33 PM
$MDXH earnings today not sure if they have enough strong news to end the short term downtrend….positive earnings will likely not be enough
0 · Reply
EdwardChoate516
EdwardChoate516 Nov. 7 at 4:39 PM
$MDXH moves steadily as investors revisit healthcare tech. AITX expands further into healthcare systems, offering AI solutions that enhance safety and visibility.
0 · Reply
thingkfast
thingkfast Oct. 28 at 8:55 PM
$MDXH easy swing, $LUCD is next in line
0 · Reply
slick3333
slick3333 Oct. 28 at 8:18 PM
$MDXH man loved that $5 break and close now what?
0 · Reply
Raxothus
Raxothus Oct. 28 at 7:37 PM
EOD CONTINUATION FOLLOW-UP – 10/27/25 Tracking continuation watchlist performance based on intraday highs vs. close ✅ $SCLX – Closed 18.90 → HOD 20.02 (+5.9%) clean push and held above VWAP. ✅ $DTCK – Closed 1.56 → HOD 1.79 (+14.7%) solid continuation with strong early volume. ⚠️ $SOHO – Moved sideways, no major follow-through, still holding range. ✅ $MDXH – Closed 4.77 → HOD 5.33 (+11.7%) continuation confirmed with strength off VWAP. ⚠️ $AARD – Closed 11.66 → HOD 12.16 (+4.3%) minor push, limited follow-through. Recap: 5 total → 3 winners ($SCLX, $DTCK, $MDXH), 2 neutral ($SOHO, $AARD) → 60% accuracy Notes: Healthy continuation day across small-cap setups; strength came from names holding VWAP with expanding volume into open. Momentum remains constructive heading into mid-week. #vwap #smallcaps #daytrading #eodfollowup #continuation #snipersetup
0 · Reply
DARKP00L
DARKP00L Oct. 28 at 3:35 PM
$MDXH 11:15 on Oct. 28 2025 Watching MDxHealth; Hearing Zacks Under $10 Newsletter Mentions Stock As A Buy #tradeideas
0 · Reply
KUMU
KUMU Oct. 28 at 3:24 PM
$MDXH swing trade into friday
0 · Reply